Cargando…

TLR9 Binding to Beclin 1 and Mitochondrial SIRT3 by a Sodium-Glucose Co-Transporter 2 Inhibitor Protects the Heart from Doxorubicin Toxicity

SIMPLE SUMMARY: We described the existence of an integrated Beclin 1, TLR9, and SIRT3 network involving autophagy, oxidative stress, and mitochondria that is essential for empagliflozin to protect against doxorubicin toxicity in the heart. Empagliflozin treatment increases the abundance of mitochond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chao-Yung, Chen, Chun-Chi, Lin, Mei-Hsiu, Su, Hui-Ting, Ho, Ming-Yun, Yeh, Jih-Kai, Tsai, Ming-Lung, Hsieh, I-Chang, Wen, Ming-Shien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693736/ https://www.ncbi.nlm.nih.gov/pubmed/33138323 http://dx.doi.org/10.3390/biology9110369

Ejemplares similares

The role of Asprosin in patients with dilated cardiomyopathy
por: Wen, Ming-Shien, et al.
Publicado: (2020)

Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus
por: Tsai, Ming-Lung, et al.
Publicado: (2023)

Nano-Resveratrol: A Promising Candidate for the Treatment of Renal Toxicity Induced by Doxorubicin in Rats Through Modulation of Beclin-1 and mTOR
por: Alhusaini, Ahlam M., et al.
Publicado: (2022)

Co-delivery of doxorubicin and shRNA of Beclin1 by folate receptor targeted pullulan-based multifunctional nanomicelles for combinational cancer therapy
por: Chen, Lili, et al.
Publicado: (2018)

Angiographic Complete versus Clinical Selective Incomplete Percutaneous Revascularization in Heart Failure Patients with Multivessel Coronary Disease
por: Chang, Chieh-Yu, et al.
Publicado: (2020)

Tlr9 and Beclin 1 Cross-Talk Regulates Muscle AMPK Activation in Exercise
por: Liu, Yang, et al.
Publicado: (2020)

Sodium, Glucose and Dysregulated Glucagon Secretion: The Potential of Sodium Glucose Transporters
por: Armour, Sarah L., et al.
Publicado: (2022)

Low-level laser prevents doxorubicin-induced skeletal muscle atrophy by modulating AMPK/SIRT1/PCG-1α-mediated mitochondrial function, apoptosis and up-regulation of pro-inflammatory responses
por: Ou, Hsiu-Chung, et al.
Publicado: (2021)

Impact of Homocysteine Level on Long-term Cardiovascular Outcomes in Patients after Coronary Artery Stenting
por: Yeh, Jih-Kai, et al.
Publicado: (2017)

POLG R964C and GBA L444P mutations in familial Parkinson's disease: Case report and literature review
por: Hsieh, Pei‐Chen, et al.
Publicado: (2019)

Impact of Sodium–Glucose Co-Transporter 2 Inhibitors on Cardiac Protection
por: Wu, Victor Chien-Chia, et al.
Publicado: (2021)

TLR9 deficiency alleviates doxorubicin‐induced cardiotoxicity via the regulation of autophagy
por: Guo, Zhen, et al.
Publicado: (2020)

Prodigiosin-Emerged PI3K/Beclin-1-Independent Pathway Elicits Autophagic Cell Death in Doxorubicin-Sensitive and -Resistant Lung Cancer
por: Chiu, Wei-Jun, et al.
Publicado: (2018)

Role of sodium‐glucose transporters in glucose uptake of the intestine and kidney
por: Harada, Norio, et al.
Publicado: (2012)

Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database
por: Zhao, Hui, et al.
Publicado: (2023)

FTO modulates fibrogenic responses in obstructive nephropathy
por: Wang, Chao-Yung, et al.
Publicado: (2016)

Recent Dermatological Treatments for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japan
por: Hsieh, Ming-Hsiu, et al.
Publicado: (2021)

SIRT1 attenuates sepsis-induced acute kidney injury via Beclin1 deacetylation-mediated autophagy activation
por: Deng, Zhiya, et al.
Publicado: (2021)

Beclin 1 acetylation impairs the anticancer effect of aspirin in colorectal cancer cells
por: Sun, Ting, et al.
Publicado: (2017)

Outcomes and Characteristics of Patients Undergoing Percutaneous Angioplasty Followed by Below-Knee or Above-Knee Amputation for Peripheral Artery Disease
por: Mao, Chun-Tai, et al.
Publicado: (2014)

Short- and Long-Term Major Cardiovascular Adverse Events in Carotid Artery Interventions: A Nationwide Population-Based Cohort Study in Taiwan
por: Tsai, Ming-Lung, et al.
Publicado: (2015)

Transarterial Chemoembolization Using Gelatin Sponges or Microspheres Plus Lipiodol-Doxorubicin versus Doxorubicin-Loaded Beads for the Treatment of Hepatocellular Carcinoma
por: Liu, Yi-Sheng, et al.
Publicado: (2015)

Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis
por: Chen, Ming-Yao, et al.
Publicado: (2021)

Percentage genome change and chromosome 7q amplification predict sorafenib response in advanced hepatocellular carcinoma
por: Yu, Ming-Chin, et al.
Publicado: (2021)

Xenophagy of invasive bacteria is differentially activated and modulated via a TLR-TRAF6-Beclin1 axis in echinoderms
por: Shao, Yina, et al.
Publicado: (2022)

Molecular mechanism of therapeutic approaches for human gastric cancer stem cells
por: Hsieh, Hsi-Lung, et al.
Publicado: (2022)

Lecithin-Stabilized Polymeric Micelles (L(sb)PMs) for Delivering Quercetin: Pharmacokinetic Studies and Therapeutic Effects of Quercetin Alone and in Combination with Doxorubicin
por: Chang, Chia-En, et al.
Publicado: (2018)

Tanshinone IIA Restores Dynamic Balance of Autophagosome/Autolysosome in Doxorubicin-Induced Cardiotoxicity via Targeting Beclin1/LAMP1
por: Wang, Xiaoping, et al.
Publicado: (2019)

Tumor progression-dependent angiogenesis in gastric cancer and its potential application
por: Hsieh, Hsi-Lung, et al.
Publicado: (2019)

Dengue Nonstructural Protein 1 Maintains Autophagy through Retarding Caspase-Mediated Cleavage of Beclin-1
por: Lu, Zi-Yi, et al.
Publicado: (2020)

Sodium-dependent glucose transporter 1 and glucose transporter 2 mediate intestinal transport of quercetrin in Caco-2 cells
por: Li, Suyun, et al.
Publicado: (2020)

TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study
por: Bertozzi, Serena, et al.
Publicado: (2021)

Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment
por: D'Onofrio, Nunzia, et al.
Publicado: (2021)

Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway
por: Hu, Can, et al.
Publicado: (2020)

Doxorubicin-induced ovarian toxicity
por: Ben-Aharon, Irit, et al.
Publicado: (2010)

MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation
por: Schirone, Leonardo, et al.
Publicado: (2023)

Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3
por: Zhang, Wei, et al.
Publicado: (2023)

Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway
por: Wang, Shudong, et al.
Publicado: (2017)

Association of Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and Incidence of Gout in Taiwan
por: Chung, Mu-Chi, et al.
Publicado: (2021)

Medication counselling with sodium glucose transporter 2 inhibitor therapy
por: Kalra, Sanjay, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oub11h5muo6rrjqbejlka33hed